Fundz

Acuamark Diagnostics, Inc. reported raising $2.29 Million in an initial SEC Form D filing, from an offering of $5.32 Million

PRIVATESep 25, 2019$2.3M of $5.3M raised

Amount Raised

$2.29 Million

$2.29 Million sold, per SEC Form D (first sale Sep 25, 2019)

Round Type

Seed

New YorkOtherInformation TechnologyHealthcare

Who else raised in Healthcare around the same time

Companies in the same sectors as Acuamark Diagnostics, Inc. that raised within 45 days of this round, from Fundz verified event records.

Who to call at Acuamark Diagnostics, Inc., and when

A new round usually means Acuamark Diagnostics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Acuamark Diagnostics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Acuamark Diagnostics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Acuamark Diagnostics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Acuamark Diagnostics, Inc.

Location

101 Avenue of the Americas

New York, New York, United States

About

Acuamark Diagnostics develops technology to allow for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced scientific team, it is Acuamark Diagnostics' mission to contribute to the global battle against cancer by detecting and attacking cancer through high-precision, early detection.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Acuamark Diagnostics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsBernard P., Executive Officer, Director, Promoter hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Acuamark Diagnostics, Inc.'s next move

See what Strategic adds

Acuamark Diagnostics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.